ClinicalTrials.gov record
Completed Not applicable Interventional

Physical Therapy After Reverse Total Shoulder Arthroplasty

ClinicalTrials.gov ID: NCT03547726

Public ClinicalTrials.gov record NCT03547726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Physical Therapy After Reverse Total Shoulder Arthroplasty: A Randomized Clinical Trial

Study identification

NCT ID
NCT03547726
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of Alabama at Birmingham
Other
Enrollment
100 participants

Conditions and interventions

Interventions

  • Physical Therapy Other
  • Self-Rehab Other

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2019
Primary completion
Jan 17, 2022
Completion
Jan 18, 2022
Last update posted
Jan 31, 2022

2019 – 2022

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UAB Hospital Highlands Birmingham Alabama 35205

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03547726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2022 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03547726 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →